Drug induced gynecomastia has infrequently been reported in the medical literature, but is probably more common than is suspected. A case report illustrating spironolactone induced gynecomastia is presented and various aspects of the condition are discussed, including mechanism of action and treatment.
Get full access to this article
View all access options for this article.
References
1.
BrownJ. J..: Comparison of Surgery and Prolonged Spironolactone Therapy in Patients with Hypertension, Br. Med. J.2: 229–234, 1972.
2.
ClarkE.: Spironolactone Therapy and Gynecomastia, Br. Med. J.193: 157, 1965.
3.
GreenblattD.,.: Gynecomastia and Impotence; Complications of Spironolactone Therapy, J. Am. Med. Assoc.223: 82, 1973.
4.
GreenblattD. J.Koch-WeserJ.: Adverse Reactions to Spironolactone, J. Am. Med. Assoc.225: 40, 1973.
5.
MannN. M.: Gynecomastia During Therapy with Spironolactone, J. Am. Med. Assoc.184: 778–780, 1963.
6.
RestifoR. A..: Spironolactone and Gynecomastia, Lancet2: 280, 1963.
7.
SmithW. G.: Spironolactone and Gynecomastia, Lancet2: 280, 1962.
8.
SparkR. F.: Aldosterone in Hypertension, Ann. Intern. Med.69: 685–691, 1968.
WilliamsM.: Gynecomastia Its Incidence, Recognition and Host Characterization in 447 Autopsy Cases, Am. J. Med.34: 103 (Jan.) 1963.
16.
NydickM.BustosJ.,.: Gynecomastia in Adolescent Boys, J. Am. Med. Assoc.178: 449, 1961.
17.
Editorial: Gynecomastia, J. Am. Med. Assoc.228: 1423, 1974.
18.
SteelmanS. L..: Anti-androgenic Activity of Spironolactone, Steroids14: 449–450, 1969.
19.
TrevesN.: Gynecomastia. The Origins of Mammary Swelling in the Male; An Analysis of 406 Patients with Breast Hypertrophy, 25 with Testicular Neoplasms, and 13 with Adrenal Neoplasms, Cancer11: 1083, 1953.
20.
WheelerC. E.CrawleyE. P..: Gynecomastia; A Review and Analysis of 160 Cases. Ann. Intern. Med.40: 985, 1954.
21.
PincusG.RomanoffL. P.CarloJ. The Excretion of Urinary Steroids by Men and Women of Various Ages, J. Gerontol.9: 113, 1954.
22.
WilliamsR. N.: Textbook of Endocrinology, Philadelphia, W. B. Saunders1973. p. 358–361.
23.
D'ArcyP. F.GriffinJ. P.: Iatrogenic Diseases, New York, N. Y., Oxford University Press1972, p. 115.
24.
Editorial: Side Effects of Methyldopa, Br. Med. J.1: 646 (Mar.) 1975.
25.
AlexanderW. D.: Letter, Side Effects of Methyldopa, Br. Med. J.2: 501 (May) 1975.
26.
PettingerW. A.HorwitzD.SjoerdamaA.: Lactation Due to Methyldopa, Br. Med. J.1: 1460, 1963.
27.
DymlingJ. F.,.: The Effects of Solactona on Plasma Testosterone and Androstenedione and Urinary 17-ketosteroids and 17-hydroxycorticosteroids, Acta. Endocr.70: 104, 1972.
28.
RodsteinM.: Gynecomastia, An Unusual Manifestation of Digitalis Toxicity, G. P. 26: 95–96, 1962.
29.
DallJ. L.: Digitalis Intoxication in Elderly Patients, Lancet1: 194, 1965.
30.
SingerE. P.: Gynecomastia Following Digitalis Administration, J. Med. Soc. New Jersey64: 557–559, 1967.
31.
BluteJ. F.: On the Noncardiac Toxicity of Digitalis, Ariz. Med.32: 320–322, 1975.
32.
HarrisonC. E.: Unusual Reaction to Common Cardiovascular Drugs, J. Med. Assoc. Georgia59: 117–1201970.
33.
BurckhardtD.,.: Effect of Digitalis on Urinary Pituitary Gonadotropin Excretion, Ann. Intern. Med.68: 1069–1071, 1968.
34.
LeWinnE. B.: Gynecomastia During Digitalis Therapy, N. Engl. J. Med.248: 316, 1953.
35.
NevabA.: Estrogen-Like Activity of Digitalis, J. Am. Med. Assoc.194: 30, 1965.
36.
Von CapellerD.,.: Digitalis Intoxication: A Clinical Report of 148 Cases, Ann. Intern. Med.50: 8691959.
37.
HoraceW.: Digitalis and Gynecomastia. J. Am. Med. Assoc.190: 1018–1019, 1964.
38.
CalovW. L.,.: Edema and Mammary Hypertrophy: A Toxic Effect of Digitalis Leaf, Med. J. Australia41: 556, 1954.
39.
MargolisI. B.: Gynecomastia During Phenothiazine Therapy, J. Am. Med. Assoc.199: 942, 1967.
